
Orexigen Therapeutics, Inc. – NASDAQ:OREX
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 5 hours
Orexigen Therapeutics key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -1.61 |
Revenue | 75.28M |
EBITDA | -11.23M |
Income | -24.52M |
Revenue Q/Q | 169.96% |
Revenue Y/Y | 204.09% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -14.92% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOrexigen Therapeutics stock price history
Orexigen Therapeutics stock forecast
Orexigen Therapeutics financial statements
Dec 2016 | 13.88M | -24.52M | -176.65% |
---|---|---|---|
Mar 2017 | 19.14M | -69.08M | -360.86% |
Jun 2017 | 23.35M | -30.51M | -130.66% |
Sep 2017 | 18.90M | 99.60M | 526.93% |
0%
Yield TTM
Payout ratio | 0% |
---|
2013 | |
---|---|
2014 | |
2015 | 0.22% |
2016 | 75.6% |
Dec 2016 | 304589000 | 247.54M | 81.27% |
---|---|---|---|
Mar 2017 | 236383000 | 244.23M | 103.32% |
Jun 2017 | 189999000 | 232.02M | 122.12% |
Sep 2017 | 183747000 | 246.11M | 133.94% |
Dec 2016 | -33.70M | 61.88M | -9.92M |
---|---|---|---|
Mar 2017 | -49.93M | 48.08M | -13.97M |
Jun 2017 | -40.12M | 38K | 47K |
Sep 2017 | -16.28M | 24.99M | 90K |
Orexigen Therapeutics other data
-
When is Orexigen Therapeutics's next earnings date?
Unfortunately, Orexigen Therapeutics's (OREX) next earnings date is currently unknown.
-
Does Orexigen Therapeutics pay dividends?
No, Orexigen Therapeutics does not pay dividends.
-
What is Orexigen Therapeutics's stock symbol?
Orexigen Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "OREX".
-
How do i buy shares of Orexigen Therapeutics?
Shares of Orexigen Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Orexigen Therapeutics went public?
Orexigen Therapeutics, Inc. is publicly traded company for more then 18 years since IPO on 26 Apr 2007.